-
1
-
-
0037126649
-
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States
-
Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137:947-954.
-
(2002)
Ann Intern Med
, vol.137
, pp. 947-954
-
-
Ostapowicz, G.1
Fontana, R.J.2
Schiodt, F.V.3
Larson, A.4
Davern, T.J.5
Han, S.H.6
-
2
-
-
56149105113
-
Using controlled clinical trials to learn more about acute drug-induced liver injury
-
Watkins PB, Seligman PJ, Pears JS, Avigan MI, Senior JR. Using controlled clinical trials to learn more about acute drug-induced liver injury. Hepatology 2008; 48:1680-1689.
-
(2008)
Hepatology
, vol.48
, pp. 1680-1689
-
-
Watkins, P.B.1
Seligman, P.J.2
Pears, J.S.3
Avigan, M.I.4
Senior, J.R.5
-
4
-
-
77951553451
-
Drug-induced liver injury: Past, present and future
-
Daly AK. Drug-induced liver injury: past, present and future. Pharmacogenomics 2010; 11:607-611.
-
(2010)
Pharmacogenomics
, vol.11
, pp. 607-611
-
-
Daly, A.K.1
-
5
-
-
79960941531
-
Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry. The dilemma of the relationship to autoimmune hepatitis
-
Lucena MI, Kaplowitz N, Hallal H, Castiella A, Garcia-Bengoechea M, Otazua P, et al. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry. The dilemma of the relationship to autoimmune hepatitis. J Hepatol 2011.
-
(2011)
J Hepatol
-
-
Lucena, M.I.1
Kaplowitz, N.2
Hallal, H.3
Castiella, A.4
Garcia-Bengoechea, M.5
Otazua, P.6
-
6
-
-
58149347349
-
Drug-Induced Liver Injury Network (DILIN) prospective study: Rationale, design and conduct
-
Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, et al. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf 2009; 32:55-68.
-
(2009)
Drug Saf
, vol.32
, pp. 55-68
-
-
Fontana, R.J.1
Watkins, P.B.2
Bonkovsky, H.L.3
Chalasani, N.4
Davern, T.5
Serrano, J.6
-
7
-
-
67649859295
-
HLAB* 5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
-
Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe er I, Floratos A, et al. HLAB* 5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009; 41:816-819.
-
(2009)
Nat Genet
, vol.41
, pp. 816-819
-
-
Daly, A.K.1
Donaldson, P.T.2
Bhatnagar, P.3
Shen, Y.4
Pe Er, I.5
Floratos, A.6
-
8
-
-
33745174840
-
EUDRAGENE: European collaboration to establish a case-control DNA collection for studying the genetic basis of adverse drug reactions
-
Molokhia M, McKeigue P. EUDRAGENE: European collaboration to establish a case-control DNA collection for studying the genetic basis of adverse drug reactions. Pharmacogenomics 2006; 7:633-638.
-
(2006)
Pharmacogenomics
, vol.7
, pp. 633-638
-
-
Molokhia, M.1
McKeigue, P.2
-
9
-
-
18744376412
-
Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period
-
Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Pachkoria K, Garcia-Ruiz E, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005; 129:512-521.
-
(2005)
Gastroenterology
, vol.129
, pp. 512-521
-
-
Andrade, R.J.1
Lucena, M.I.2
Fernandez, M.C.3
Pelaez, G.4
Pachkoria, K.5
Garcia-Ruiz, E.6
-
10
-
-
79957523368
-
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class i and II alleles
-
Lucena MI, Molokhia M, Shen Y, Urban TJ, Aithal GP, Andrade RJ, et al. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 2011.
-
(2011)
Gastroenterology
-
-
Lucena, M.I.1
Molokhia, M.2
Shen, Y.3
Urban, T.J.4
Aithal, G.P.5
Andrade, R.J.6
-
11
-
-
0027362542
-
Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries
-
Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. a novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46:1323-1330.
-
(1993)
J Clin Epidemiol
, vol.46
, pp. 1323-1330
-
-
Danan, G.1
Benichou, C.2
-
12
-
-
50949096560
-
The Population Reference Sample, POPRES: A resource for population, disease, and pharmacological genetics research
-
Nelson MR, Bryc K, King KS, Indap A, Boyko AR, Novembre J, et al. The Population Reference Sample, POPRES: a resource for population, disease, and pharmacological genetics research. Am J Hum Genet 2008; 83:347-358.
-
(2008)
Am J Hum Genet
, vol.83
, pp. 347-358
-
-
Nelson, M.R.1
Bryc, K.2
King, K.S.3
Indap, A.4
Boyko, A.R.5
Novembre, J.6
-
13
-
-
70349292099
-
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
-
Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461:399-401.
-
(2009)
Nature
, vol.461
, pp. 399-401
-
-
Ge, D.1
Fellay, J.2
Thompson, A.J.3
Simon, J.S.4
Shianna, K.V.5
Urban, T.J.6
-
14
-
-
33746512512
-
Principal components analysis corrects for stratification in genome-wide association studies
-
Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38:904-909.
-
(2006)
Nat Genet
, vol.38
, pp. 904-909
-
-
Price, A.L.1
Patterson, N.J.2
Plenge, R.M.3
Weinblatt, M.E.4
Shadick, N.A.5
Reich, D.6
-
15
-
-
34548292504
-
PLINK: A tool set for whole-genome association and population-based linkage analyses
-
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-575.
-
(2007)
Am J Hum Genet
, vol.81
, pp. 559-575
-
-
Purcell, S.1
Neale, B.2
Todd-Brown, K.3
Thomas, L.4
Ferreira, M.A.5
Bender, D.6
-
16
-
-
41649083448
-
WGAViewer: Software for genomic annotation of whole genome association studies
-
Ge D, Zhang K, Need AC, Martin O, Fellay J, Urban TJ, et al. WGAViewer: software for genomic annotation of whole genome association studies. Genome Res 2008; 18:640-643.
-
(2008)
Genome Res
, vol.18
, pp. 640-643
-
-
Ge, D.1
Zhang, K.2
Need, A.C.3
Martin, O.4
Fellay, J.5
Urban, T.J.6
-
17
-
-
19944429040
-
A single-nucleotide polymorphism tagging set for human drug metabolism and transport
-
Ahmadi KR, Weale ME, Xue ZY, Soranzo N, Yarnall DP, Briley JD, et al. A single-nucleotide polymorphism tagging set for human drug metabolism and transport. Nat Genet 2005; 37:84-89.
-
(2005)
Nat Genet
, vol.37
, pp. 84-89
-
-
Ahmadi, K.R.1
Weale, M.E.2
Xue, Z.Y.3
Soranzo, N.4
Yarnall, D.P.5
Briley, J.D.6
-
18
-
-
67249117049
-
Potential etiologic and functional implications of genome-wide association loci for human diseases and traits
-
Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009; 106:9362-9367.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 9362-9367
-
-
Hindorff, L.A.1
Sethupathy, P.2
Junkins, H.A.3
Ramos, E.M.4
Mehta, J.P.5
Collins, F.S.6
-
19
-
-
44149127481
-
PGA: Power calculator for casecontrol genetic association analyses
-
Menashe I, Rosenberg PS, Chen BE. PGA: power calculator for casecontrol genetic association analyses. BMC Genet 2008; 9:36.
-
(2008)
BMC Genet
, vol.9
, pp. 36
-
-
Menashe, I.1
Rosenberg, P.S.2
Chen, B.E.3
-
20
-
-
25444509248
-
Power and sample size calculations in the presence of phenotype errors for case/ control genetic association studies
-
Edwards BJ, Haynes C, Levenstien MA, Finch SJ, Gordon D. Power and sample size calculations in the presence of phenotype errors for case/ control genetic association studies. BMC Genet 2005; 6:18.
-
(2005)
BMC Genet
, vol.6
, pp. 18
-
-
Edwards, B.J.1
Haynes, C.2
Levenstien, M.A.3
Finch, S.J.4
Gordon, D.5
-
21
-
-
55249101270
-
STAT4: Genetics, mechanisms, and implications for autoimmunity
-
Korman BD, Kastner DL, Gregersen PK, Remmers EF. STAT4: genetics, mechanisms, and implications for autoimmunity. Curr Allergy Asthma Rep 2008; 8:398-403.
-
(2008)
Curr Allergy Asthma Rep
, vol.8
, pp. 398-403
-
-
Korman, B.D.1
Kastner, D.L.2
Gregersen, P.K.3
Remmers, E.F.4
-
22
-
-
0036140937
-
Diclofenac antagonizes peroxisome proliferator-activated receptor-gamma signaling
-
Adamson DJ, Frew D, Tatoud R, Wolf CR, Palmer CN. Diclofenac antagonizes peroxisome proliferator-activated receptor-gamma signaling. Mol Pharmacol 2002; 61:7-12.
-
(2002)
Mol Pharmacol
, vol.61
, pp. 7-12
-
-
Adamson, D.J.1
Frew, D.2
Tatoud, R.3
Wolf, C.R.4
Palmer, C.N.5
-
23
-
-
77955270210
-
Modulation of inflammatory changes in early stages of colon cancer through activation of PPARgamma by diclofenac
-
Kaur J, Sanyal SN. Modulation of inflammatory changes in early stages of colon cancer through activation of PPARgamma by diclofenac. Eur J Cancer Prev 2010; 19:319-327.
-
(2010)
Eur J Cancer Prev
, vol.19
, pp. 319-327
-
-
Kaur, J.1
Sanyal, S.N.2
-
24
-
-
53849149299
-
Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma
-
Zieleniak A,Wojcik M,Wozniak LA. Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma. Arch Immunol Ther Exp (Warsz) 2008; 56:331-345.
-
(2008)
Arch Immunol Ther Exp (Warsz)
, vol.56
, pp. 331-345
-
-
Zieleniak, A.1
Wojcik, M.2
Wozniak, L.A.3
-
25
-
-
78649824344
-
Liver tests are irrelevant when prescribing statins
-
Bader T. Liver tests are irrelevant when prescribing statins. Lancet 2010; 376:1882-1883.
-
(2010)
Lancet
, vol.376
, pp. 1882-1883
-
-
Bader, T.1
-
26
-
-
77955082302
-
A genomewide study identifies HLA alleles associated with lumiracoxib-related liver injury
-
Singer JB, Lewitzky S, Leroy E, Yang F, Zhao X, Klickstein L, et al. A genomewide study identifies HLA alleles associated with lumiracoxib-related liver injury. Nat Genet 2010; 42:711-714.
-
(2010)
Nat Genet
, vol.42
, pp. 711-714
-
-
Singer, J.B.1
Lewitzky, S.2
Leroy, E.3
Yang, F.4
Zhao, X.5
Klickstein, L.6
-
27
-
-
79952173247
-
HLADQA1* 02:01 Is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer
-
Spraggs CF, Budde LR, Briley LP, Bing N, Cox CJ, King KS, et al. HLADQA1* 02:01 Is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer. J Clin Oncol 2011; 29:667-673.
-
(2011)
J Clin Oncol
, vol.29
, pp. 667-673
-
-
Spraggs, C.F.1
Budde, L.R.2
Briley, L.P.3
Bing, N.4
Cox, C.J.5
King, K.S.6
-
28
-
-
44049102035
-
Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis
-
Kindmark A, Jawaid A, Harbron CG, Barratt BJ, Bengtsson OF, Andersson TB, et al. Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. Pharmacogenomics J 2008; 8:186-195.
-
(2008)
Pharmacogenomics J
, vol.8
, pp. 186-195
-
-
Kindmark, A.1
Jawaid, A.2
Harbron, C.G.3
Barratt, B.J.4
Bengtsson, O.F.5
Andersson, T.B.6
-
29
-
-
67949100442
-
Co-medications that modulate liver injury and repair influence clinical outcome of acetaminophenassociated liver injury
-
Suzuki A, Yuen N,Walsh J, Papay J, Hunt CM, Diehl AM. Co-medications that modulate liver injury and repair influence clinical outcome of acetaminophenassociated liver injury. Clin Gastroenterol Hepatol 2009; 7:882-888.
-
(2009)
Clin Gastroenterol Hepatol
, vol.7
, pp. 882-888
-
-
Suzuki, A.1
Yuen, N.2
Walsh, J.3
Papay, J.4
Hunt, C.M.5
Diehl, A.M.6
|